Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 60/100

Presentation to Extraordinary General Meeting

Wednesday, August 14, 2024 1 min read
Key Takeaway: Radiopharm Theranostics has announced the initiation of a Phase 1/2a clinical study for BetaBart (RV-01) and has received IND approval from the US FDA. The company has also shared positive clinical updates across four of its programs. This marks a significant step forward in their therapeutic development efforts.

Market Sentiment Analysis

POSITIVE FACTORS

  • Radiopharm Theranostics has initiated a Phase 1/2a clinical study.
  • The company received IND approval from the US FDA.
  • Positive updates were provided across four clinical programs.

Full Press Release Details

• Announcements
• August 14, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• June 30, 2023
• Announcements
• November 29, 2021
• Announcements
• April 22, 2024
• Announcements
• July 29, 2022

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is the BetaBart clinical study about?

The BetaBart clinical study is a Phase 1/2a trial initiated by Radiopharm Theranostics.

When did Radiopharm receive FDA approval?

Radiopharm received IND approval from the US FDA to initiate the study.

What updates were provided by Radiopharm?

Radiopharm provided positive clinical updates across four of its programs.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics BetaBart Phase 1/2a FDA approval clinical study
Last updated: Aug 14, 2024